Dogwood Therapeutics Files Resale Registration Statement for Shares Held by Largest Stockholder

Filing content

Dogwood Therapeutics filed a shelf registration statement for the resale of 4,098,360 shares of common stock held by its largest stockholder, Sealbond Limited.